Week 3 Pre Reading Flashcards
Additions to the food and drug act
Schedules C and D
Prescription drug list
Part G
Narcotic drugs and preparations
Part J
Benzodiazepines and other targeted substances regulations
Schedules C and D
Drugs in these schedule must list where the drug was made and manufacturing conditions
Prescription drug list
Replaces schedule F
List of ingredients in a drug that requires prescription
(Excluding drugs in controlled drug and substances act)
Part G (3)
Controlled drugs (affect CNS)
- labeled with a C
Three parts of categorization
1 - drugs with misuse potential that are used for designated conditions (in food and drug act)
2 - sedatives
3 - controlled drugs with misuse potential like steroids or weight reduction drugs
Narcotic drugs and preparations
Drugs with high misuse potential
- codeine, fent etc
Part J
Drugs with dangerous physiological and psychological effects with NO RECOGNIZED MEDICAL USE
Eg. LSD, psilocybin
Canadian food and drug act
Primary part of legislation governing food drugs cosmetics and medical devices in Canada
Has schedule A which lists diseases for which treatments aren’t available to the public
CSD label
Canadian standard drug
Says that the drug meets all standards
Schedule C
Radiopharmaceuticals
Schedule D
Allergenic substances, vaccines, insulin, blood derivatives
Controlled drug and substances act
Provides requirements for control and sale of narcotics, controlled drugs
Schedule I
Contains most dangerous drugs
Heroin, cocaine, etc
How many schedules contained in the controlled drug and substances act
8
Benzodiazepines and other targeted substances regulations
Specify restrictions in benzodiazepines
Precursor control regulations
Address the need for control of essential chemicals used to make meth and ecstasy
Priority review of drug submissions process
Fast track approval for life saving therapies
180 days down for 300
Drug approval process phase 1
Phase 1
- healthy people
- determine potential adverse affects, optimal dosage, pharmacokinetics
Drug approval process phase 2
Involve larger numbers of people who have the disease that the drug is designed for
- doses are refined
Drug approval process phase 3
More people
- idea is to find out rare adverse effects
- uses placebo to see if the drug is actually helpful
- tests with a control group
Drug approval process phase 4
Aftermarket monitoring
IND
Investigational new drug
Classes of drug recall from health Canada
1 2 and 3
1: most severe (can cause bad affects or death)
2: may result in temporary of medically reversible side effects
3: use of the drug is not likely to cause any major helath issues
Special access programme
Allows HCPs assess to drugs that aren’t for sale in Canada
Limited to serious or life threatening cases
Legal nursing considerations
Scope of practice
Nursing roles
Educational requirements
Standard of care
Safe practice
Differences in practice
Areas of liability for nurses
Faultier to ensure safety
Medication errors
Failure to assess or evaluate
PIPEDA
Personal information protection and electronic documents act
Protects people
Polymorphism
Effect of a patients age, gender, size, race, etc has on pharmacokinetics of drugs
P450 enzyme
Control a stage of hepatic metabolism
Different levels mean you can metabolize drugs at different speeds or dosages